Literature DB >> 12099719

Maximal ATPase activity and calcium sensitivity of reconstituted myofilaments are unaltered by the fetal troponin T re-expressed during human heart failure.

Jose R Torrealba1, Emilio Lozano, Michael Griffin, Scott Stoker, Kerry McDonald, Marion Greaser, Matthew R Wolff.   

Abstract

Re-expression of a fetal isoform of troponin T (TnT(4)) has been demonstrated in failing human ventricular myocardium and associated with a decrease in myofibrillar ATPase activity. In order to elucidate the regulatory role of the re-expressed TnT(4) in the failing human heart, we measured ATPase activity in reconstituted cardiac myofilaments prepared with recombinant human TnT(4) or the adult human isoform of troponin T (TnT(3)). Neither the maximal calcium-activated ATPase activity nor the calcium sensitivity of this biochemical assay was significantly different between reconstituted myofilaments containing adult TnT(3) or fetal TnT(4). Our results suggest that the re-expressed fetal TnT(4) is not responsible for the depressed ATPase activity of failing ventricular myofibrils. The increased expression of the fetal isoform of this thin filament regulatory protein in the failing ventricle may be a consequence of a programmed change in gene expression occurring in response to hemodynamic stress, but probably does not contribute to depressed ventricular function characteristic of dilated cardiomyopathies. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12099719     DOI: 10.1006/jmcc.2002.2016

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  2 in total

Review 1.  Kinetics and energetics of the crossbridge cycle.

Authors:  David W Maughan
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

2.  The role of a common TNNT2 polymorphism in cardiac hypertrophy.

Authors:  Kazuo Komamura; Naoharu Iwai; Koichi Kokame; Yoshio Yasumura; Jiyoong Kim; Masakazu Yamagishi; Takayuki Morisaki; Akinori Kimura; Hitonobu Tomoike; Masafumi Kitakaze; Kunio Miyatake
Journal:  J Hum Genet       Date:  2004-02-24       Impact factor: 3.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.